Navigation Links
PBL Assay Science announces ultra-sensitive assay services to measure biomolecules in human serum or plasma

PISCATAWAY, N.J., Nov. 19, 2013 /PRNewswire/ -- PBL Assay Science announces the expansion of its assay services portfolio to include 38 different ultra-sensitive biomolecule assays using the Singulex® Erenna® Immunoassay technology.  Based on an innovative single-molecule counting (SMC) technology, these services are designed to provide sub-picogram per ml sensitivity for analytes in human serum or plasma.  The background reduction methodology of this detection service extends the linear dynamic range to over 4 logs, allowing a wide concentration range of biomarker measurement with minimal dilution in many disease states.

"We are proud to offer ultra-sensitive cytokine detection services to researchers around the world," said Dr. Thomas Lavoie, Director of Product Research & Development and Assay Services at PBL.  "The ability to measure basal levels of cytokines and other biomarkers in the femtogram per ml range will enable far deeper analysis of changes in these biomarkers, enhancing our understanding of various diseases and disease therapies, and allowing for earlier project milestone decisions, saving our clients time and money."

The addition of ultra-sensitive cytokine detection services signifies PBL's commitment in providing the best service solutions to meet scientists' assay needs.  It complements the company's single-analyte ELISA, cytokine multiplex ELISA, and cell-based activity assay services that are currently offered in their sample testing and screening catalog.

Ultra-sensitive assay services offered by PBL include detection for cytokines such as human IL-17A, IL-17F, IL-17 A/F heterodimer, IL-6, IL-1alpha, IL-1beta, IL-10, IL-15, TNF-alpha, GLP-1, and biomarkers such as cardiac troponin-I.  For additional information about this technology, view our poster presented at the 2013 American Association of Pharmaceutical Scientists (AAPS) National Biotechnology Conference.  To learn more about these services, contact Stephen Parent, the company's Director of Business Development, at or 1-732-777-9123 ext. 117.

About PBL Assay Science

PBL Assay Science is a major provider of products, services, information, and know-how related to interferons, cytokines, antibodies, ELISAs, and assay solutions.  The company employs state-of-the-art technology in conducting assay services and manufacturing world-class products for scientists around the globe each day. Learn more at


Stephen A. Parent

(732) 777-9123 x 117

SOURCE PBL Assay Science
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. IntelligentMDx Receives FDA Clearance for IMDx C. difficile for Abbott m2000 Assay, Completes Move of Corporate Headquarters to Waltham
2. FDA Approves Aptima HPV 16 18/45 Genotype Assay for Use on Hologics Panther System
3. Quantum Materials Engineers Tetrapod Quantum Dots to Improve Diagnostic Accuracy of Biomedical Assays and Devices
4. Sharp Edge Labs and SpectraGenetics Sign Agreement to Provide Better Assays for Studying G-Protein Coupled Receptors
5. Beckman Coulter Receives FDA Clearance of AccuTnI+3 Troponin I Assay on UniCel DxI Immunoassay Systems
6. IntelligentMDx Receives FDA Clearance for IMDx VanR for Abbott m2000 assay
8. QIAGEN Significantly Expands its Offering of Assay Panels for Next-generation Sequencing (NGS) Complemented by Ingenuity Analysis and Interpretation Capabilities
9. Immunoassays: Technologies and Global Markets -- Focus on Infectious Disease Immunoassays
10. Markteinf├╝hrung neuer Assays f├╝r Magen-Darm Infektionen in Europa
11. Profil Institute and Mercodia Announce Partnership Offering Insulin and Metabolism ELISA Assays to Enhance Diabetes and Obesity Clinical Trials
Post Your Comments:
(Date:11/29/2015)... 2015 CIVCO Medical Solutions will demonstrate ... Radiological Society of North America ... November 29 – December 4, 2015. The ... customers unrivaled versatility, enhanced user experience and deliver ... --> --> ...
(Date:11/27/2015)... Nov. 27, 2015  Lannett Company, Inc. (NYSE: ... completed the acquisition of Kremers Urban Pharmaceuticals Inc. ... global biopharmaceuticals company UCB S.A. (Euronext: UCB). ... has acquired KU from UCB for total consideration ... including a customary working capital adjustment, a deduction ...
(Date:11/26/2015)... Carolina , 26 november 2015 /PRNewswire/ ... (AAIPharma/CML) kondigt de geplande investering aan van ... van de laboratoria en het mondiale hoofdkantoor ... De uitbreiding zal resulteren in extra kantoorruimte ... voldaan aan de groeiende behoeften van de ...
Breaking Medicine Technology:
(Date:11/28/2015)... (PRWEB) , ... November 28, 2015 , ... ... exchange technology and teleradiology services, has added Chris Hafey and Claude Hooton to ... at the Radiological Society of North America (RSNA) 2015 Annual Meeting and continues ...
(Date:11/28/2015)... ... ... Trying to relax on a couch can actually be uncomfortable, so an ... due to personal experience with a bad back," he said. , This easy-to-use, versatile ... as increases support. It also makes it easier to eat, do other activities and ...
(Date:11/28/2015)... ... November 28, 2015 , ... Pixel Film Studios is back again with ... from, the possibilities are endless. Users have full control over angle of view, speed ... effects, users are sure to get heads to turn. , ProPanel: Pulse offers fully ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published November ... meeting in Washington D.C. revolved around the fact that proper dental care, both at-home ... stressed the link between periodontal disease (more commonly referred to as gum disease) and ...
(Date:11/27/2015)... ... 2015 , ... According to an article published November 15th by ... handling security in light of the recent terrorist attacks in Paris, other cities are ... an attack from reaching U.S. soil. Especially around special events that may be high-profile ...
Breaking Medicine News(10 mins):